06.14.13
Shortly after NuVasive Inc. opened a brand new facility in Japan, the company acquired ANC LLC, along with ANC’s full-scale spine implant manufacturing facility in Dayton, Ohio. ANC has served as a manufacturing partner to NuVasive since May 2010, and ANC is currently one of NuVasive’s implant suppliers.
“We are very excited to welcome ANC’s 65-member team into the NuVasive family,” said Alex Lukianov, NuVasive’s chairman and CEO. “Over the past three years, we have been very impressed with ANC’s progression as a quality manufacturer and their cultural fit with NuVasive. The facility will be designated NuVasive Manufacturing LLC, and we look forward to expanding their capacity and systems as we grow together. Bringing portions of our manufacturing in house is a key element of our ongoing commitment to improve operating profitability as we grow toward $1 billion in revenue and beyond. With speed of innovation as a fundamental cornerstone of our success, the acquisition will reduce the time from the concept of a new idea to ultimate market introduction, enabling development and manufacturing to work seamlessly in launching our innovative solutions.”
NuVasive will pay approximately $4.5 million in the deal, assuming no debt. The 14-year-old company anticipates the transaction will be neutral to earnings in fiscal year 2013. Over the long term, however, the company expects vertical integration will provide opportunities to drive profitability improvements.
Don Knoth, owner of ANC, will remain as a consultant until the end of this year. Knoth founded the predecessor to ANC in the mid 1990s as a medical manufacturer, and sold it in 2007. At that time, the new owners closed the operation down, which prompted Knoth to buy most of the equipment back and restart the company under the ANC name.
In April, Knoth committed to a growth plan of adding 27 workers, making about $300,000 in facility improvements and buying up to $4 million worth of equipment to boost capacity over the next three years. This plan is still in place, Knoth said, post acquisition.
NuVasive is a spine device company based in San Diego, Calif. ANC manufactures minimally invasive titanium and polyetheretherketone implants.
“We are very excited to welcome ANC’s 65-member team into the NuVasive family,” said Alex Lukianov, NuVasive’s chairman and CEO. “Over the past three years, we have been very impressed with ANC’s progression as a quality manufacturer and their cultural fit with NuVasive. The facility will be designated NuVasive Manufacturing LLC, and we look forward to expanding their capacity and systems as we grow together. Bringing portions of our manufacturing in house is a key element of our ongoing commitment to improve operating profitability as we grow toward $1 billion in revenue and beyond. With speed of innovation as a fundamental cornerstone of our success, the acquisition will reduce the time from the concept of a new idea to ultimate market introduction, enabling development and manufacturing to work seamlessly in launching our innovative solutions.”
NuVasive will pay approximately $4.5 million in the deal, assuming no debt. The 14-year-old company anticipates the transaction will be neutral to earnings in fiscal year 2013. Over the long term, however, the company expects vertical integration will provide opportunities to drive profitability improvements.
Don Knoth, owner of ANC, will remain as a consultant until the end of this year. Knoth founded the predecessor to ANC in the mid 1990s as a medical manufacturer, and sold it in 2007. At that time, the new owners closed the operation down, which prompted Knoth to buy most of the equipment back and restart the company under the ANC name.
In April, Knoth committed to a growth plan of adding 27 workers, making about $300,000 in facility improvements and buying up to $4 million worth of equipment to boost capacity over the next three years. This plan is still in place, Knoth said, post acquisition.
NuVasive is a spine device company based in San Diego, Calif. ANC manufactures minimally invasive titanium and polyetheretherketone implants.